Sikhipha Tshifhiwa B, Barrett Claire, van Zyl Nicoline, van Rooyen Cornel, Bisiwe Feziwe B
Division of Nephrology, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, 205 Nelson Mandela Drive, Bloemfontein, 9300, South Africa.
Research and Development Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
BMC Nephrol. 2025 Jan 2;26(1):4. doi: 10.1186/s12882-024-03927-x.
Continuous ambulatory peritoneal dialysis (CAPD) is one of the kidney replacement therapy (KRT) modalities used in patients with kidney failure. It is the preferred modality in most resource-limited settings as it is more accessible and cost-effective. CAPD technique failure remains a challenge and is associated with an increased risk of morbidity and mortality. We aimed to describe the sociodemographic and clinical characteristics, CAPD survival rate and the reasons for CAPD technique failure over a five-year period among adult patients on CAPD at a tertiary hospital in South Africa.
We conducted a retrospective analytical study reviewing files of patients with end-stage kidney disease (ESKD) whose peritoneal dialysis (PD) catheter was removed, or who died with a functioning PD catheter while on the PD program at Universitas Academic Hospital in Bloemfontein, South Africa, from 01 January 2015 until 31 December 2019. The demographic, clinical and laboratory data were collected from patients' medical records. Clinical outcomes were technique failure and survival.
Ninety-one patient records met the inclusion criteria of whom 51 (56.0%) were male. The median age at commencement of PD was 40 years (interquartile range [IQR] 18-58). Fifty-one (57.3%) patients were single and 64 (70.0%) were unemployed. Hypertension was the leading cause of ESKD (n = 47; 51.6%), followed by human immunodeficiency virus- (HIV-) associated conditions (n = 18; 19.8%). Technique failure rates at 1-, 2-, 3-, 4- and 5-years post-PD initiation were 31.9%, 35.2%, 13.2%, 8.8% and 11.0%, respectively. The 5-year survival rate was 63.7% (n = 58), with a median survival time of 26 months (IQR 1-54). Peritonitis was the leading cause of technique failure (n = 52; 57.1%), and almost a third (n = 29 (31.9%)) had a fatal outcome. Younger age and using the Dianeal® PD system were associated with an increased likelihood of technique failure. No other sociodemographic, laboratory and clinical factors were associated with the development of technique failure or death.
PD-associated peritonitis is the primary cause of technique failure, followed by sudden unexpected death occurring at home. Preventive measures need to be adhered to in order to avoid high rates of peritonitis.
持续性非卧床腹膜透析(CAPD)是肾衰竭患者使用的肾脏替代治疗(KRT)方式之一。在大多数资源有限的环境中,它是首选方式,因为其更易获得且具有成本效益。CAPD技术失败仍然是一个挑战,并且与发病率和死亡率增加相关。我们旨在描述南非一家三级医院中接受CAPD治疗的成年患者在五年期间的社会人口学和临床特征、CAPD生存率以及CAPD技术失败的原因。
我们进行了一项回顾性分析研究,回顾了2015年1月1日至2019年12月31日期间在南非布隆方丹的尤尼韦塔斯学术医院接受腹膜透析(PD)治疗的终末期肾病(ESKD)患者的病历,这些患者的PD导管已拔除,或在PD治疗期间因功能正常的PD导管死亡。从患者的病历中收集人口统计学、临床和实验室数据。临床结局为技术失败和生存。
91份患者记录符合纳入标准,其中51例(56.0%)为男性。开始PD治疗时的中位年龄为40岁(四分位间距[IQR]18 - 58)。51例(57.3%)患者为单身,64例(70.0%)失业。高血压是ESKD的主要原因(n = 47;51.6%),其次是人类免疫缺陷病毒(HIV)相关疾病(n = 18;19.8%)。PD开始后1年、2年、3年、4年和5年的技术失败率分别为31.9%、35.2%、13.2%、8.8%和11.0%。5年生存率为63.7%(n = 58),中位生存时间为26个月(IQR 1 - 54)。腹膜炎是技术失败的主要原因(n = 52;57.1%),近三分之一(n = 29(31.9%))有致命结局。年龄较小和使用百特®腹膜透析系统与技术失败的可能性增加相关。没有其他社会人口学、实验室和临床因素与技术失败或死亡的发生相关。
与PD相关的腹膜炎是技术失败的主要原因,其次是在家中发生的意外猝死。需要坚持预防措施以避免高腹膜炎发生率。